David Tze
Gwen Cheni
Gwen is a Partner on the Investment Team at Khosla Ventures.
She was previously a Partner at IndieBio/SOSV covering bio and AI. Prior to IndieBio, Gwen was the founder and Managing Partner of Galapagos Ventures, an early stage venture fund focused on the intersection of biology and AI/ML. She was an early investor in SyntheX, Intrinsic Medicine, and Huue. Prior to Galapagos Ventures, she was a Director at StudioX (machine learning venture studio funded by Shell and Boston Consulting Group) and a Venture Partner at Fusion Fund (early stage fund focused on AI/ML, robotics and devices). Gwen was on the Board of Advisors at Singularity University Ventures, an impact-focused accelerator, and helped launch their first batch of startups in the Nordics.
Prior to venture, Gwen spent eighteen years on Wall Street investing in public equities, started her career at Goldman Sachs, JPMorgan, and was promoted to portfolio manager at a $300 million innovation-themed hedge fund.
Gwen is the author of a chapter in a Physics textbook on lasers, second author on two publications in immuno-oncology, and co-owner of a patent on magnetic resonance. She currently sits on the Advisory Board of the Yale University School of Medicine.
Gwen received her bachelor’s degree in economics (math track) with a minor in computer science electrical engineering from Yale University. She received her MBA from the University of Chicago. Gwen also spent two years at UCSF researching immunotherapy for glioblastomas, and was second author on two publications.
Craig Wilson
Marcel Bens
Dr. Michael Taylor
- Founder, Former President and CEO, MARS (MultiPlan Payment Integrity Solutions)
- President of MultiPlan’s Payment Integrity division
- Founded MARS as a technologically-enabled provider of healthcare payment integrity services for payers and third-party administrators
- VP of Operations at Executive Health Resources, acquired by Optum in 2010.
- Previously medical director for Aetna / Schaller Anderson, as well as co-Founder and President of a rural family medicine practice.
- Michael is a graduate of Vanderbilt University School of Medicine and Harvard College
Dale Carr
Dale Carr currently serves as Director of the Missouri Medicaid Audit & Compliance (MMAC) unit, which
has overall responsibility for Medicaid program integrity efforts. Dale has worked for the State of
Missouri since 2011. Director Carr was previously a Police Officer in Fallon, NV; an Investigator for the
U.S. Office of Special Counsel; and a Supervisory Special Agent with the Coast Guard Investigative
Service. Dale holds a Bachelor’s degree in Administration of Criminal Justice and is a graduate of the
158th Session of the FBI National Academy.
Helen Li
Helen Liis an associate director of patents and patent portfolio manager of AI innovations at the Intel Corporation. She also serves as the Patent Group Counsel to Office of the Intel CTO & Software and Advanced Technology Group. Prior to joining the Intel, she was a patent attorney at Fenwick & West LLP, where she advised clients on IP strategy and prosecuted patents in computer engineering technologies such as AI. She has a PhD in computer engineering and JD both from Santa Clara University.
